Immunohistochemistry ALK1 Test: Advanced Cancer Detection and Treatment Planning
Understanding the Immunohistochemistry ALK1 Test
The Immunohistochemistry ALK1 Test represents a cutting-edge diagnostic approach in modern oncology that specifically targets the detection of anaplastic lymphoma kinase (ALK) gene rearrangements in cancer tissues. This sophisticated laboratory technique utilizes specialized antibodies to identify the presence and distribution of ALK proteins within tumor cells, providing critical insights for personalized cancer treatment strategies.
What Does the ALK1 Test Measure?
This advanced diagnostic test specifically detects:
- ALK protein overexpression in tumor tissue samples
- Gene rearrangements involving the ALK gene
- Specific protein patterns indicative of ALK-positive cancers
- Cellular localization of ALK proteins within tumor architecture
Clinical Importance and Applications
The Immunohistochemistry ALK1 Test plays a vital role in contemporary cancer management by identifying patients who are likely to respond to ALK inhibitor therapies. This targeted approach has revolutionized treatment outcomes for individuals with ALK-positive cancers, particularly non-small cell lung cancer (NSCLC). The test’s ability to provide rapid, reliable results makes it an essential component of comprehensive cancer care protocols.
Who Should Consider This Test?
This diagnostic test is particularly recommended for:
- Patients diagnosed with non-small cell lung cancer
- Individuals with advanced or metastatic lung cancer
- Patients who have not responded to conventional chemotherapy
- Those being evaluated for targeted therapy options
- Individuals with specific cancer types where ALK rearrangements are known to occur
Key Benefits of ALK1 Testing
Undergoing the Immunohistochemistry ALK1 Test offers numerous advantages:
- Personalized Treatment Planning: Identifies patients who may benefit from targeted ALK inhibitor therapies
- Improved Treatment Outcomes: Helps select the most effective treatment approach for specific cancer subtypes
- Reduced Side Effects: Enables targeted therapy selection, potentially minimizing unnecessary treatment toxicity
- Comprehensive Cancer Profiling: Provides valuable information about tumor biology and behavior
- Informed Decision Making: Empowers patients and physicians with crucial diagnostic information
Understanding Your Test Results
Your Immunohistochemistry ALK1 Test results will typically fall into one of several categories:
Positive Result Interpretation
A positive result indicates the presence of ALK protein expression in the tumor tissue, suggesting that the cancer may respond to ALK inhibitor medications. This finding opens the door to targeted treatment options that can be more effective and better tolerated than conventional therapies.
Negative Result Interpretation
A negative result means that ALK protein expression was not detected in the tested tissue sample. While this may indicate that ALK-targeted therapies might not be the most appropriate choice, it helps guide physicians toward alternative treatment strategies that may be more suitable for your specific cancer type.
Equivocal or Borderline Results
In some cases, results may be inconclusive or borderline. Your healthcare provider will discuss these findings with you and may recommend additional testing or alternative diagnostic approaches to ensure accurate treatment planning.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry ALK1 Test | $76 USD | $126 USD |
Sample Requirements and Processing
The Immunohistochemistry ALK1 Test requires specific sample preparation:
- Sample Type: Tumor tissue in 10% formal-saline OR formalin-fixed paraffin-embedded block
- Shipping Instructions: Ship at room temperature with proper packaging
- Required Documentation: Copy of histopathology report, biopsy site information, and clinical history
- Turnaround Time: Results typically available within 10 business days
Nationwide Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.
Take the Next Step in Your Cancer Care Journey
Don’t leave your treatment decisions to chance. The Immunohistochemistry ALK1 Test provides critical information that can significantly impact your cancer treatment outcomes. Our team of experienced oncologists and pathologists are ready to help you access this important diagnostic tool.
Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our dedicated healthcare professionals are available to answer your questions and guide you through the testing process.
